Opposing effects of tumor necrosis factor‐α and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N‐formyl‐methionyl‐leucyl‐phenylalanine
- 1 April 1992
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 22 (4) , 969-974
- https://doi.org/10.1002/eji.1830220414
Abstract
Tumor necrosis factor (TNF) as well as the hematopoietic growth factors interleukin‐3, interleukin‐5, and granulocyte‐macrophage colony‐stimulating factor affect several eosinophil functions. We previously reported (J. Exp. Med. 1989. 170: 467; 1990. 172: 1577) that the hematopoietic growth factors also potentiate leukotriene C4 (LTC4) formation by eosinophils as well as basophils stimulated with soluble chemotactic peptides such as N‐formyl‐methionyl‐leucyl‐phenylalanine (FMLP), but whether TNF also modulates lipid mediator generation in normodense eosinophils triggered with FMLP is unkonwn. Here we show that a short preincubation (10 min) of human eosinophils purified from healthy donors with low concentrations of TNF (5‐150 pM) strongly enhances LTC4 formation in response to FMLP. However, basophil mediator release is not affected by TNF preincubation. Nerve growth factor (NGF), the receptor of which is structurally related to the TNF receptors, tended to suppress lipid mediator synthesis in eosinophils, in contrast to its profound potentiating capacity on basophil mediator release. Thus, the present study demonstrates a first difference in susceptibility of eosinophils and basophils towards cytokines, indicating that TNF and NGF may regulate the relative importance of effector functions of these otherwise closely related cell types.Keywords
This publication has 30 references indexed in Scilit:
- Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.Journal of Clinical Investigation, 1991
- The trk proto-oncogene encodes a receptor for nerve growth factorCell, 1991
- Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.The Journal of Experimental Medicine, 1990
- The divergent receptors for TNFTrends in Biochemical Sciences, 1990
- Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium.The Journal of Experimental Medicine, 1990
- Interleukin 3-dependent mediator release in basophils triggered by C5a.The Journal of Experimental Medicine, 1989
- Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals.The Journal of Experimental Medicine, 1988
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985